|
Volumn 106, Issue , 2005, Pages 135-191
|
Radionuclide-peptide nucleic acid in diagnosis and treatment of pancreatic cancer.
a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CHELATING AGENT;
CYCLIN D1;
DIAGNOSTIC AGENT;
ENZYME INHIBITOR;
MYC PROTEIN;
PEPTIDE;
PEPTIDE NUCLEIC ACID;
RADIOISOTOPE;
TECHNETIUM;
ANIMAL;
APOPTOSIS;
CHEMICAL MODEL;
CHEMISTRY;
CONFORMATION;
GENETICS;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
MASS SPECTROMETRY;
METHODOLOGY;
ONCOGENE RAS;
PANCREAS TUMOR;
PROTO ONCOGENE;
REVIEW;
SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;
TUMOR SUPPRESSOR GENE;
ANIMALS;
APOPTOSIS;
CHELATING AGENTS;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
CYCLIN D1;
ENZYME INHIBITORS;
GENES, ERBB-2;
GENES, P53;
GENES, RAS;
HUMANS;
MODELS, CHEMICAL;
NUCLEIC ACID CONFORMATION;
PANCREATIC NEOPLASMS;
PEPTIDE NUCLEIC ACIDS;
PEPTIDES;
PROTO-ONCOGENE PROTEINS C-MYC;
RADIOISOTOPES;
SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;
TECHNETIUM;
TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;
|
EID: 16544380853
PISSN: 15431894
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (11)
|
References (186)
|